BOCA RATON, Fla., March 13 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals announced today that Dr. Leslie Hudson, president and chief executive officer will participate in the Lehman Brothers Tenth Annual Global Healthcare Conference on Monday, March 19, 2007, at the Loewes Miami Beach Hotel in Miami, Florida. Dr. Hudson will present a company overview including a review of Nabi’s new corporate strategy at 1:30 p.m. eastern time.
The live webcast can be accessed at: http://cc.talkpoint.com?LEHM002/031907a_jw/default.asp?entity=Nabi The webcast presentation will be available through April 19, 2007. About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions. The company has two products on the market today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection. Nabi Biopharmaceuticals is focused on developing products that address unmet medical needs and offer commercial opportunities in our core business areas: Hepatitis and transplant, Gram-positive bacterial infections and nicotine addiction. For a complete list of pipeline products, please go to: http://www.nabi.com/pipeline/index.php. The company is headquartered in Boca Raton, Florida. For additional information about Nabi Biopharmaceuticals, please visit our website at http://www.nabi.com.
Nabi Biopharmaceuticals
CONTACT: Tom Rathjen, Vice President, Investor Relations of NabiBiopharmaceuticals, +1-561-989-5800
